FDA Approves New Alzheimer's Drug Kinsula, Offering Hope to Patients
Kisunla, a new FDA-approved drug, is being hailed as a "miracle" for its potential to treat Alzheimer's disease by improving memory and cognitive functions. Administered as a once-a-month injection, it offers hope to those in the early stages of dementia. The Baker Senior Center in Naples, where the drug is being celebrated, continues to support Alzheimer's patients with various programs, emphasizing hope and community.